These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 20832545)

  • 1. Peritransplant monitoring of immune cell function in adult living donor liver transplantation.
    Hwang S; Kim KH; Song GW; Yu YD; Park GC; Kim KW; Choi NK; Park PJ; Choi YI; Jung DH; Ahn CS; Moon DB; Ha TY; Lee SG
    Transplant Proc; 2010 Sep; 42(7):2567-71. PubMed ID: 20832545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of the effect of living donor liver transplantation on the treatment of severe hepatitis].
    Li G; Wen TF; Yan LN; Chen ZY; Zeng Y; Li B; Zhao JC; Wang WT; Yang JY; Xu MQ; Ma YK; Wu H
    Zhonghua Gan Zang Bing Za Zhi; 2009 Mar; 17(3):184-7. PubMed ID: 19335980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Living donor liver transplantation for hepatitis B cirrhosis.
    Sugawara Y; Makuuchi M; Kaneko J; Akamatsu N; Imamura H; Kokudo N
    Liver Transpl; 2003 Nov; 9(11):1181-4. PubMed ID: 14586879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor stem cell infusion after non-myeloablative conditioning for tolerance induction to HLA mismatched adult living-donor liver graft.
    Donckier V; Troisi R; Toungouz M; Colle I; Van Vlierberghe H; Jacquy C; Martiat P; Stordeur P; Zhou L; Boon N; Lambermont M; Schandené L; Van Laethem JL; Noens L; Gelin M; de Hemptinne B; Goldman M
    Transpl Immunol; 2004; 13(2):139-46. PubMed ID: 15380544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Living donor liver transplantation in patients with hepatitis C.
    Zimmerman MA; Trotter JF
    Liver Transpl; 2003 Nov; 9(11):S52-7. PubMed ID: 14586896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. K(ICG) value, a reliable real-time estimator of graft function, accurately predicts outcomes in adult living-donor liver transplantation.
    Hori T; Iida T; Yagi S; Taniguchi K; Yamamoto C; Mizuno S; Yamagiwa K; Isaji S; Uemoto S
    Liver Transpl; 2006 Apr; 12(4):605-13. PubMed ID: 16555326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of tacrolimus in living donor liver transplant and deceased donor liver transplant recipients.
    Jain A; Venkataramanan R; Sharma R; Kwong T; Orloff M; Abt P; Kashyap R; Tsoulfas G; Batzold P; Williamson M; Bozorgzadeh A
    Transplantation; 2008 Feb; 85(4):554-60. PubMed ID: 18347534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes of living donor liver transplantation for hepatitis C virus (HCV)-positive patients.
    Takada Y; Haga H; Ito T; Nabeshima M; Ogawa K; Kasahara M; Oike F; Ueda M; Egawa H; Tanaka K
    Transplantation; 2006 Feb; 81(3):350-4. PubMed ID: 16477219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for invasive aspergillosis in living donor liver transplant recipients.
    Osawa M; Ito Y; Hirai T; Isozumi R; Takakura S; Fujimoto Y; Iinuma Y; Ichiyama S; Tanaka K; Mishima M
    Liver Transpl; 2007 Apr; 13(4):566-70. PubMed ID: 17394155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early postoperative renal dysfunction in the adult living donor liver transplantation.
    Lee SK; Park JB; Kim SJ; Choi GS; Kim DJ; Kwon CH; Lee SK; Joh JW
    Transplant Proc; 2007 Jun; 39(5):1517-9. PubMed ID: 17580177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Living donor liver transplant with clinical tolerance, laboratory evidence of chimerism, and spontaneous clearance of HBV.
    Stone JJ; Chang SH; Kimball PM; Stravitz RT; Fisher RA
    Liver Transpl; 2004 Nov; 10(11):1432-5. PubMed ID: 15497148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Splenic abscess after splenic artery ligation in living donor liver transplantation: a case report.
    Balci D; Taner B; Dayangac M; Akin B; Yaprak O; Duran C; Uraz S; Hayzaran S; Ayanoglu O; Killi R; Senturk H; Yuzer Y; Tokat Y
    Transplant Proc; 2008 Jun; 40(5):1786-8. PubMed ID: 18589197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of plasmapheresis therapy for perioperative management in ABO-incompatible adult living donor liver transplantation.
    Ashizawa T; Matsuno N; Yokoyama T; Kihara Y; Kuzuoka K; Taira S; Konno O; Jyojima Y; Akashi I; Nakamura Y; Hama K; Iwamoto H; Iwahori T; Nagao T; Kasahara M; Tanaka K
    Transplant Proc; 2006 Dec; 38(10):3629-32. PubMed ID: 17175351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful living donor liver transplantation using a graft from a hepatitis B surface antigen-positive donor.
    Soejima Y; Shimada M; Taketomi A; Yoshizumi T; Uchiyama H; Ikegami T; Nakamuta M; Maehara Y
    Liver Int; 2007 Nov; 27(9):1282-6. PubMed ID: 17919241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of 100 patients for living donor liver transplantation.
    Trotter JF; Wachs M; Trouillot T; Steinberg T; Bak T; Everson GT; Kam I
    Liver Transpl; 2000 May; 6(3):290-5. PubMed ID: 10827228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A significant expansion of CD8+ CD28- T-suppressor cells in adult-to-adult living donor liver transplant recipients.
    Lin YX; Yan LN; Li B; Wang LL; Wen TF; Zeng Y; Wang WT; Zhao JC; Yang JY; Xu MQ; Ma YK; Chen ZY; Bai YJ
    Transplant Proc; 2009 Dec; 41(10):4229-31. PubMed ID: 20005374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Living donor liver transplant recipients achieve relatively higher immunosuppressant blood levels than cadaveric recipients.
    Trotter JF; Stolpman N; Wachs M; Bak T; Kugelmas M; Kam I; Everson GT
    Liver Transpl; 2002 Mar; 8(3):212-8. PubMed ID: 11910565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Living donor liver transplantation for hepatitis C-related cirrhosis: no difference in histological recurrence when compared to deceased donor liver transplantation recipients.
    Guo L; Orrego M; Rodriguez-Luna H; Balan V; Byrne T; Chopra K; Douglas DD; Harrison E; Moss A; Reddy KS; Williams JW; Rakela J; Mulligan D; Vargas HE
    Liver Transpl; 2006 Apr; 12(4):560-5. PubMed ID: 16555313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major influence of liver function itself but not of immunosuppression determines glucose tolerance after living-donor liver transplantation.
    Stockmann M; Konrad T; Nolting S; Hünerbein D; Wernecke KD; Döbling H; Steinmüller T; Neuhaus P
    Liver Transpl; 2006 Apr; 12(4):535-43. PubMed ID: 16496277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Living donor liver transplantation for hepatitis B cirrhosis.
    Karasu Z; Akyildiz M; Kilic M; Zeytunlu M; Aydin U; Tekin F; Yilmaz F; Ozacar T; Akarca U; Ersoz G; Gunsar F; Ilter T; Lucey MR
    J Gastroenterol Hepatol; 2007 Dec; 22(12):2124-9. PubMed ID: 18031369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.